Table 3.
Patients’ characteristics | Patients’ perceived severity of COPD
|
P-value | ||
---|---|---|---|---|
Very severe/severe (%) | Moderate (%) | Mild (%) | ||
Sex | <0.001 | |||
Males | 42.4 | 29.6 | 28.0 | |
Females | 19.3 | 39.7 | 41.0 | |
Age group (years) | <0.001 | |||
40–49 | 15.4 | 25.6 | 59.0 | |
50–59 | 13.7 | 30.0 | 56.3 | |
60–69 | 30.2 | 38.4 | 31.4 | |
>70 | 46.9 | 36.5 | 16.6 | |
BMI group | 0.117 | |||
Underweight/normal weight | 26.7 | 33.3 | 40.0 | |
Overweight | 37.2 | 29.0 | 33.8 | |
Obese | 28.9 | 42.3 | 28.8 | |
Smoking status | 0.127 | |||
Current smoker | 27.2 | 35.9 | 36.9 | |
Ex-smoker | 40.0 | 31.8 | 28.2 | |
Nonsmoker | 26.1 | 36.1 | 37.8 | |
Passive smoking | 0.610 | |||
Yes | 27.8 | 38.3 | 33.9 | |
No | 32.7 | 31.9 | 35.4 | |
Environmental smoke | 0.230 | |||
Yes | 16.6 | 33.4 | 50.0 | |
No | 34.1 | 34.1 | 32.8 | |
Comorbidities | 0.314 | |||
Any comorbidity | 31.3 | 35.3 | 33.4 | |
No comorbidity | 38.1 | 19.0 | 42.9 | |
COPD + asthma | 0.140 | |||
No | 40.2 | 30.5 | 29.3 | |
Yes | 29.2 | 35.4 | 35.4 | |
Years passed since COPD diagnosis | 0.001 | |||
<5 years from diagnosis | 19.4 | 38.0 | 42.6 | |
5–10 years from diagnosis | 39.4 | 27.9 | 32.7 | |
>10 years from diagnosis | 39.6 | 35.2 | 25.2 | |
CAT score | <0.001 | |||
<10 | 3.7 | 5.6 | 90.7 | |
≥10 | 36.4 | 40.3 | 23.3 | |
mMRC grade | <0.001 | |||
Mild breathlessness (0–1) | 17.5 | 31.6 | 50.9 | |
Moderate breathlessness (2–3) | 39.5 | 43.2 | 17.3 | |
Severe breathlessness (4) | 80.6 | 12.9 | 6.5 | |
Exacerbations during the past 12 months | <0.001 | |||
No exacerbation | 14.9 | 30.3 | 54.8 | |
Exacerbation | 47.5 | 37.6 | 14.9 | |
GOLD categorya | <0.001 | |||
A | 4.2 | 4.2 | 91.6 | |
B | 19.3 | 42.1 | 38.6 | |
D | 48.2 | 38.7 | 13.1 |
Notes:
Only six patients were in GOLD category C, and therefore were excluded. Bold indicates the statistically significant results at a level of 5%.
Abbreviations: BMI, body mass index; CAT, COPD assessment test; GOLD, Global initiative for chronic Obstructive Lung Disease; COPD, chronic obstructive pulmonary disease; mMRC, modified Medical Research Council.